![Marc Banjak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 31 750 $ al 31/08/2026
Marc A. Banjak is currently Chief Legal Officer at iBio, Inc. since 2025.
Formerly, Mr. Banjak was General Counsel at Istari Oncology, Inc., General Counsel at Dova Pharmaceuticals, Inc. from 2017 to 2021, and a Member of The Colorado Bar Association.
Education includes undergraduate studies at Franklin & Marshall College and graduate studies at Sturm College of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IBIO, INC. 0,07 % | 26/03/2026 | 25.000 ( 0,07 % ) | 31 750 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IBIO, INC. | Consejero General | - |
| Empresas | Cargo | Fin |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Consejero General | 01/04/2021 |
The Colorado Bar Association | Corporate Officer/Principal | - |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Colorado Bar Association | |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Sturm College of Law
 Sturm College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
